SFX by Ex Libris Inc.

Title:	Male pseudohermaphroditism caused by mutations of testicular 17β–hydroxysteroid dehydrogenase 3
Source:	Nature Genetics [1061-4036] Geissler, Wayne yr:1994

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Kamath, Ravi S S. "Systematic functional analysis of the Caenorhabditis elegans genome using RNAi." Nature 421.6920 (2003): 231-237.
description	2.	Schuster, D. "Identification of chemically diverse, novel inhibitors of 17β-hydroxysteroid dehydrogenase type 3 and 5 by pharmacophore-based virtual screening." The Journal of steroid biochemistry and molecular biology 125.1-2 (2011): 148-161.
description	3.	KREMER, H. "MALE PSEUDOHERMAPHRODITISM DUE TO A HOMOZYGOUS MISSENSE MUTATION OF THE LUTEINIZING-HORMONE RECEPTOR GENE." Nature genetics 9.2 (1995): 160-164.
description	4.	Fung, K-M M. "Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma." Endocrine-related cancer 13.1 (2006): 169-80.
description	5.	Fraser, A.G. G. "Functional genomic analysis of C. elegans chromosome I by systematic RNA interference." Nature 408.6810 (2000): 325-330.
description	6.	Sönnichsen, B. "Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans." Nature 434.7032: 462-469.
description	7.	fire, A. "potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans." Nature 391.6669: 806-811.
description	8.	Koushika, S P P. "A post-docking role for active zone protein Rim." Nature neuroscience 4.10 (2001): 997-1005.
description	9.	Tabara, H. "RNAi in C. elegans: Soaking in the Genome Sequence." Science 282.5388 (1998): 430-1.
description	10.	Bennett, Nigel C. "Evidence for Steroidogenic Potential in Human Prostate Cell Lines and Tissues." The American journal of pathology 181.3 (2012): 1078-1087.
description	11.	Kratschmar, Denise V. "Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2." The Journal of steroid biochemistry and molecular biology 125.1-2 (2011): 129-142.
description	12.	Byrns, Michael C. "An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent m." Biochemical pharmacology 75.2 (2008): 484-493.
description	13.	Dozmorov, Mikhail G. "Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progressioan." BMC cancer 10.1 (2010): 672-.
description	14.	Brozic, P. "Cinnamic acids as new inhibitors of 17 beta-hydroxy steroid dehydrogenase type 5 (AKR1C3)." Molecular and Cellular Endocrinology 248.1-2 (2006): 233-235.
description	15.	Ribeiro, M L L. "Novel human pathological mutations. Gene symbol: TPI1. Disease: triosephosphate isomerase deficiency." Human genetics 125.3 (2007): 650-335.
description	16.	Stefansson, H. "Neuregulin 1 and susceptibility to schizophrenia." American journal of human genetics 71.4 (2002): 877-92.
description	17.	Elbashir, S M M. "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells." Nature 411.6836 (2001): 494-498.
description	18.	Hannon, G. "RNA interference." Nature 418.6894 (2002): 244-251.
description	19.	Caplen, N J J. "Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems." Proceedings of the National Academy of Sciences of the United States of America 98.17 (2001): 9742-7.
description	20.	Montgomery, M K K. "RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans." Proceedings of the National Academy of Sciences of the United States of America 95.26 (1999): 15502-7.